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Introduction 
 
Asymmetric reduction of carbonyl and heterocarbonyl functionalities arguably belongs 
to the class of fundamental organic transformations. In the racemic realm, the reducing 
reagents, such as metal hydrides, are usually competent to reduce both ketones and 
ketimines. 1  However, the asymmetric methods that work well for ketones, are often 
considerably less efficient for ketimines, and vice versa.2 There are only a limited number of 
catalytic systems that exhibit high selectivity with both compound classes, e.g., a highly 
efficient Cu-catalysed hydrosilylation of ketones and ketimines developed by Lipshutz.3  
Asymmetric reduction of ketones 1 and ketimines 2 with trichlorosilane, catalysed by 
chiral Lewis bases (Scheme 1), recently emerged as an efficient methodology4 capable of 
competing with the traditional, transition metal-mediated processes2 and other organocatalytic 
methods.5,6 The field has witnessed an exponential growth in the last decade after Matsumura7  
had reported on useful enantioselectivities in the reduction of ketones (up to 43% ee) and 
ketimines (up to 66% ee), employing the proline-derived formamide 5b as a chiral catalyst 
(Chart 1). Formamides 5-8,8,9 picolinamides 9-11,10 and sulfinamides 12 and 1311 represent the 
major catalyst types for the asymmetric reduction of ketimines (Chart 1). Of these, the 
commercially available valine-derived Kenamide 6a and Sigamide 6b, developed by us,8 are 
among the most versatile catalysts, delivering high enantioselectivity over a broad substrate 
range.  
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In a preliminary communication 12  we have reported on a novel design of 
organocatalysts based on the pyridyl-oxazoline core, such as 14 and 16,13 which proved equally 
efficient in the reduction of aromatic ketones 1 and ketimines 2 (Scheme 1 and Chart 2). Later, 
Sun9e introduced catalyst 7c, which also shared that ability. Herein, we present a full account of 
the development of pyridyl-oxazoline type catalysts 14-28 and reveal new applications.  
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Chart 1. The most successful Lewis-basic organocatalysts for asymmetric reduction of ketones 
and ketimines with trichlorosilane. 
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Chart 2. Pyridine-derived catalysts for asymmetric reduction of ketones and ketimines with 
trichlorosilane. 
Results and Discussion 
Catalyst design and synthesis. Design of our catalysts takes its origin in the successful 
series of chelating nitrogen ligands containing pyridine and oxazoline fragments; 14  their 
selection is shown in Chart 2. The oxazolines derived from pyridine (14-21), quinoline (26), and 
isoquinoline (27) were synthesised following the method described by Brunner as follows 
(Scheme 2):15 2-cyano pyridines 29a-e were first converted into the corresponding imidates 
30a-e by the reaction with a catalytic quantity of sodium methoxide in methanol.  Acid-
catalysed cyclization of the latter imidates 30a-e with the appropriate amino alcohols 31a-f 
afforded the desired oxazolines 14-21 in the yields ranging from 31% (18) to 89% (21). The 
preparation of 14-1612,14 and 26, 2712 was described earlier.  
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The reaction of chiral amino alcohols 31 with imidates 30 proceeds with retention of 
configuration at the stereogenic centre as both amino and hydroxy groups of the amino alcohol 
act as nucleophiles, with methanol and ammonia being displaced from the imidate. In order to 
drive the equilibrium towards the oxazoline product, the reaction was carried out at an 
elevated temperature with argon bubbling through the reaction mixture to remove methanol 
and ammonia from the system. 
The requisite amino alcohols 31 were synthesised in our laboratory, except for the 
commercially available (S)-leucinol 31a and (S)-phenylglycinol 31b. Thus, (S)-31c and (R)-31c 
were prepared from the (S) and (R) enantiomers of mandelic acid, respectively, which were first 
converted into the enantiomeric amides, followed by reduction with LiAlH4.12 The synthesis of 
amino alcohols 31d-f was accomplished in two steps via cyanation of the carbonyl compounds 
32a-c, followed by reduction of the resulting nitriles (Scheme 3). Under the optimised 
conditions, the zinc(II) catalysed cyanosilylation16 of the carbonyl functionality was carried out 
in neat trimethylsilyl cyanide to give the trimethylsilyl protected cyanohydrins, which were then 
in situ reduced with LiAlH4 to afford racemic amino alcohols 31d-f. 
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Amino alcohol 31d was resolved by co-crystallisation with (S)-(+)-mandelic acid from hot 
ethanol. After two crystallisations, (+)-31d was obtained in 92% ee, as revealed by chiral GC 
analysis. Resolution of the other amino alcohols was not attempted; however, the 
enantiomerically pure oxazoline 21 was obtained from a racemate by preparative chiral HPLC. 
The synthesis of imidazolines (R)-22 and (R)-23 was achieved by the reaction of imidate 
30a and diamines (R)-35 and (R)-38, respectively (Scheme 4). The latter diamines were 
synthesised from methyl phenylglycinate hydrochloride (R)-33 as follows: the latter starting 
material was converted into diamine (R)-35 in two steps by first forming amide (R)-34 with N-
methylamine, followed by reduction with lithium aluminium hydride. To obtain amine (R)-38, 
ester (R)-33 was first converted into amide (R)-36 on reaction with aqueous ammonia.  Amide 
(R)-36 was then treated with di-tert-butyl carbonate to give the Boc-derivative (R)-37, which 
was subsequently reduced with lithium aluminium hydride to afford diamine (R)-38.  
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For the synthesis of 1-isoquinolyloxazoline 28, a different strategy was employed due to 
the high cost of 1-isoquinolinecarbonitrile (Scheme 5). The preparation commenced with 
amidation of the commercially available 1-isoquinoline carboxylic acid 39 with mandelamine 
(R)-31c using the mixed anhydride method. The resulting amide (R)-40 (89%) was then treated 
with mesyl chloride in the presence of triethylamine to effect cyclization, which proceeded with 
inversion of configuration at the stereogenic centre. The desired 1-isoquinoline oxazoline (S)-28 
was recrystallised from ethanol and isolated as a white solid in 95% yield.  
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Synthetic sequences towards thiazolines 24 and 25 (as analogues of 16 and 28), are 
shown in Scheme 6. The synthesis of pyridyl-thiazoline 24 began with the preparation of 
thioester 42 from 2-chloromethylpyridine 41 on reaction with sulfur, followed by treatment 
with methyl iodide.17 The resulting thioester 42 was then coupled with amino alcohol (R)-31c in 
THF in the presence of triethylamine to afford thioamide (R)-43 (78%). Cyclization was then 
achieved by treating the latter thioamide with mesyl chloride, furnishing thiazoline (S)-24 
(82%). Hydroxy amide (R)-40 was chosen as a starting material for the synthesis of catalyst (S)-
25. First, thionation of the latter amide with Lawesson’s reagent in HMPA18 was attempted but 
the conversion was very low and the desired thioamide could not be isolated from the crude 
reaction mixture. In a modified protocol, hydroxy amide (R)-40 was first converted into the 
TBDMS ether (R)-44; subsequent treatment with the Lawesson’s reagent in toluene at 85 oC 
overnight, followed by acidic work-up and flash chromatography, was successful and furnished 
thiazoline (S)-25 in 78% yield. The latter thionation of 44 is accompanied by removal of the 
TBDMS protecting group and the resulting intermediate alcohol is then presumably derivatized 
by Lawesson’s reagent,19 to generate a leaving group (via a P-O bond formation), followed by 
cyclisation to produce (S)-25 with inversion of configuration. 
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Asymmetric reduction of ketones with trichlorosilane. Our preliminary investigation 
focused on the reduction of aromatic ketones with trichlorosilane in the presence of 20 mol% 
of 2-pyridyl oxazolines (Table 1). Oxazolines (S)-14 and (S)-15, derived from phenylglycine and 
leucine, respectively, exhibited modest conversion and enantioselectivity in the reduction of 
acetophenones 1a at -20 oC in chloroform (entries 1 and 2). Interestingly, under the same 
conditions, the isomeric oxazoline (S)-16, derived from mandelic acid, and with the chiral centre 
further away from the (presumably) coordinating nitrogen, catalysed the formation of alcohol 
(R)-3a at a better conversion (85%) and with an improved enantiomeric excess (78% ee, entry 
4). A brief investigation of the solvent effect revealed a minor decrease in enantioselectivity for 
dichloromethane compared to chloroform (cf entries 7 and 4); in THF, further drop in ee was 
accompanied by low conversion (entry 8), whereas in acetonitrile and toluene both conversion 
and ee were negligible. The reaction temperatures of -20 oC or -30 oC appear to be optimal in 
terms of performance (entries 4 and 5) but -20 oC is preferred for operational convenience. An 
expected fall in enantioselectivity was observed at room temperature (entry 3). On the other 
hand, decreasing the temperature to –40 oC had a detrimental effect on both the conversion 
and enantioselectivity (entry 6).  
The influence of steric and electronic properties of the pyridine moiety on the catalyst 
efficiency was investigated with the aid of 2-pyridyl oxazolines 17 and 18. It turned out that 
introduction of a phenyl substituent at the 6-position of the pyridine ring, as in 17, rendered 
the catalyst completely inactive (entry 20), presumably as a result of increasing the steric 
hindrance in the vicinity of the anticipated coordination site. Increasing the Lewis basicity of the 
pyridine nitrogen by incorporating the electron-donating 4-methoxy substituent (18) did not 
improve the catalyst activity either (entry 21). 
The initial screening identified 2-pyridyl oxazoline (S)-16 as the best catalysts and CHCl3 
at -20 oC as the optimal reaction conditions. Next, the reaction scope was assessed by 
employing a range of ketones 1a-l (Table 1). Propiophenone 1b (entry 9) reacted similarly to 
acetophenone 1a (cf. entries 9 and 4) but the more sterically demanding isopropylphenyl 
ketone 1c proved unreactive (entry 10). 2-Acetylnaphthalenes 1d and 1e, and 4-
methylacetophenone 1f were more reactive than 1a, showing enantioselectivities around 80% 
ee (entries 11-13). Reduction of 4-methoxy acetophenone 1h (entry 15) turned out to be less 
enantioselective (43% ee), which may stem from partial racemisation of the scalemic product 
under the reaction conditions or during the workup. This reaction was also accompanied by a 
notable formation of by-products. The latter effect, however, was not manifested in the case of 
the 2-methoxy isomer 1g (entry 14), which gave the product of practically the same 
enantiopurity as 1a. Electron-withdrawing substituents in 1j and 1k had a detrimental effect on 
the reaction rates and led to lower enantioselectivities (entries 16, 18). 2-Bromoacetophenone 
1j, which represents a combination of the unfavourable electronic and steric factors, was found 
to be completely inactive (entry 17). Finally, the non-aromatic ketone 1l gave a racemic product 
(entry 19).   
Table 1.  Reduction of Ketones with Trichlorosilane.a 
R1 R2
O
R1 R2
OH
1 3
*
Cl3SiH, cat.
solvent
T (oC), 16 h  
Entry Catalyst Ketone R1, R2 Solvent Temp (oC) Conversion (%)a 3, ee (%)
 
1 (S)-14 1a Ph, Me CHCl3 −20 29 66 (S) 
2 (S)-15 1a Ph, Me CHCl3 −20 34 54 (S) 
3 (S)-16 1a Ph, Me CH2Cl2 rt 40 64 (R)  
4 (S)-16 1a Ph, Me CHCl3 −20 85 78 (R)  
5 (S)-16 1a Ph, Me CHCl3 −30 94 78 (R)  
6 (S)-16 1a Ph, Me CHCl3 −40 6 69 (R)  
7 (S)-16 1a Ph, Me CH2Cl2 −20 83 74 (R)  
8 (S)-16 1a Ph, Me THF −20 30 70 (R) 
9 (S)-16 1b Ph, Et CHCl3 −20 91 80 (R) 
10 (S)-16 1c Ph, i-Pr CH2Cl2 −20 0 - 
11 (S)-16 1d 2-Naphthyl, Me CHCl3 −20 99 80 (R) 
12 (S)-16 1e 6’-Me-Naphth-2-yl, Me CHCl3 −20 99 83 (R) 
13 (S)-16 1f 4-Me-C6H4, Me CHCl3 −20 96 80 (R) 
14 (S)-16 1g 2-MeO-C6H4, Me CHCl3 −20 99 77 (R) 
15 (S)-16 1h 4-MeO-C6H4, Me CH2Cl2 −20 65 43 (R) 
16 (S)-16 1i 2-F-C6H4, Me CHCl3 −20 30 70 (R) 
17 (S)-16 1j 2-Br-C6H4, Me CH2Cl2 −20 0 - 
18 (S)-16 1k 4-CF3-C6H4, Me CHCl3 −20 47 71 (R) 
19 (S)-16 1l c-Hex, Me CH2Cl2 −20 67 0 
20 (S)-17 1a Ph, Me CH2Cl2 0 0 - 
21 (S)-18 1a Ph, Me CH2Cl2 0 10 25 (R) 
aThe reactions were carried out at 0.4 mmol scale using 20 mol% catalyst loading. Conversion and ee’s were 
determined by chiral GC.  
The encouraging level of enantioselectivities attained with catalyst 16 set the scene for 
further development. First, we focused on lowering the relatively high catalyst loading (20 
mol%). Since we observed that the oxazoline moiety of (R)-16 was undergoing a slow, chloride-
promoted ring opening, giving rise to the chloro derivative (S)-45 (Scheme 7), we initially 
focused on this problem. It can be assumed that in the reaction mixture the oxazoline ring is 
strongly activated towards nucleophilic attack either by protonation (originating from the HCl 
that is always present in Cl3SiH as a contaminant) or by coordination of the Lewis-acidic 
silicon,20 either of which could facilitate the undesired gradual ring-opening at the benzylic 
position.  
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In an attempt to discourage the chloride-promoted ring opening of the oxazoline 
moiety, 2-pyridyloxazolines 19-21 (Chart 2) were synthesised.21 The ring opening via an SN2 
mechanism should be blocked in 19, although the susceptibility to SN1 would be increased.  
Ring opening via SN1 mechanism would be disfavoured in the case of 20, where the electron-
withdrawing trifluoromethyl group in the aryl ring should destabilise the carbocation 
intermediate. This does however increase the electrophilicity of the benzylic carbon and thus 
the likelihood of an SN2 reaction. Finally, a neopentyl carbon centre, as in the t-butyl 
substituted oxazoline 21, should disfavour the ring opening by either mechanism. However, 
neither of the new catalysts 19-21 (Table 2) turned out to be able to bring any advantage over 
the mandelic acid-derived 16 (compare entry 1 with entries 2-4). The drop in enantioselectivity 
for (S)-19 is likely to originate in the steric hindrance introduced by the methyl to the bottom 
face of the catalyst. Only the oxazoline (S)-21, carrying a t-Bu group, performed comparably to 
16 (entry 4). Anyway, in all three cases, the oxazoline moiety was found to undergo gradual 
decomposition.  
Table 2. Reduction of 1a with Trichlorsilane Catalysed by 5-Subtituted Oxazolines.a  
Entry Catalyst Solvent Temp (oC) Conversion (%)a 3, ee (%)
 
1 (S)-16 CH2Cl2 −20 83 74 (R) 
2 (S)-19 CH2Cl2 rt 63 34 (R) 
3 (±)-20b,c CHCl3 −20 72 -  
4 (S)-21b CH2Cl2 −20 85 68 (R)  
5 (R)-22b CHCl3 −20 51 34 (R)  
6 (R)-23b CHCl3 −20 17 34 (S)  
7 (S)-24 CHCl3 −20 25d 64 (R)  
8 (S)-25 CH2Cl2 −20    0 - 
aThe reactions were carried out at 1 mmol scale using 20 mol% catalyst loading. Conversion and ee’s were 
determined by chiral GC. b10 mol% catalyst loading. cRacemic catalyst. dIsolated yield.  
Next, we reasoned that replacing the oxazoline moiety with imidazoline or thiazoline 
fragments (22-25) would prevent the chloride-promoted ring-opening as the decreased 
electronegativity of nitrogen and sulfur should reduce the propensity for a nucleophilic attack 
at the benzylic position. Pyridine imidazolines (R)-22 and (R)-23 and thiazoline (S)-24 can be 
viewed as analogues of 2-pyridyl oxazolines (R)-14 and (R)-16, whereas thiazoline (S)-25 
represents an analogue with an extended aromatic system. However, catalysts 22-24 turned 
out to be considerably less reactive than the parent oxazoline 16 (Table 2, entries 5-7). Only 
thiazoline 24 showed acceptable enantioselectivity (entry 7), whereas imidazolines 22 and 23 
produced much lower ee and the isoquinoline-derived oxazoline 25 was found to be inert 
(entry 8). Thus, although these new catalysts did not bring about any improvement in terms of 
activity, the imidazoline and thiazoline moieties proved to be stable (compared to the 
oxazolines), as no decomposition was observed under the reaction conditions. 
The reactivity of ketones in the reduction with trichlorosilane catalysed by 16 displays a 
good correlation with their Brønsted basicity (pKHB): 2-MeO-C6H4COMe (1.34) > PhCOMe (1.11) 
> 2-F-C6H4COMe (0.90).22 Assuming that this trend can be extrapolated to Lewis basicity, this 
behaviour suggests that, in the transition state, the carbonyl oxygen is either coordinated to 
the weakly Lewis acidic trichlorosilane or connected to the catalytically active species via 
hydrogen bonding (originating from the omnipresent traces of HCl).23 A linear relationship 
observed between the enantiopurity of the catalyst and the product of the reduction of 
acetophenone 1a with trichlorosilane catalysed by 16 indicates that only one molecule of the 
catalyst is actively participating in the enantiodiscriminating step.12 Based on the available 
experimental data, we can tentatively suggest possible transition structures (Scheme 8): N,N-
Chelation of trichlorosilane by the catalyst can be predicted to generate an activated 
hypervalent species A, which then coordinates the carbonyl group upon replacement of a 
chloride atom to form B. Alternatively, the catalyst could act in a monodentate fashion, 
whereby the protonated second nitrogen serves as a hydrogen bond donor for the incoming 
ketone (C). The lack of enantioselectivity for non-aromatic ketones may also suggest a potential 
role of arene-arene interactions in the enantiodiscrimination event.24In the related Lewis base-
catalysed addition of allyltrichlorosilanes to aromatic aldehydes, computational analysis 
indicated a substantial contribution of arene-arene interactions between the catalyst and the 
substrate to the stereochemical outcome of the process.25 Therefore, quinoline (26) and 
isoquinoline (27 and 28) derivatives, featuring an extended π-system, were synthesised. The 
results of the catalytic reduction of ketones with trichlorosilane employing these catalysts are 
presented in Table 3.  
Scheme 8. 
 
 
 
Table 3: Reduction of Ketones 1 with Trichlorosilane Catalyzed by 25-28.a 
 
entry Catalyst (mol%) ketone R
1, R2 yield (%)b ee (%)c,d 
1 (R)-26 (20) 1a Ph, Me    0e - 
2 (R)-27 (20) 1a Ph, Me   41e 73 
3 (S)-28 (20) 1a Ph, Me  80e 76 
4 (S)-28 (20) 1a Ph, Me 72 84 
5 (S)-28 (10) 1a Ph, Me 85 84 
6 (S)-28 (10) 1b Ph, Et 55 86 
7 (S)-28 (10) 1d 2-Naphth, Me 93 94 
8 (S)-28 (10) 1e 6-Me-2-Naphth, Me 93 92 
9 (S)-28 (10) 1f 4-Me-C6H4, Me 90 85 
10 (S)-28 (10) 1g 2-MeO-C6H4, Me  50f 87 
11 (S)-28 (10) 1i 2-F-C6H4, Me 35 70 
12 (S)-28 (10) 1l Cyclohexyl, Me 77 0 
13 (S)-28 (10) 1m Cinnamyl, Me   52g 16 
a The reactions were carried out on 0.4 mmol scale with 2.1 equiv. of HSiCl3 in CHCl3 in the presence of 
catalyst 7 for 24 h (unless stated otherwise). b Isolated yield (product pure by 1H NMR). c All products 2 were 
of (R)-configuration (unless stated otherwise) as revealed by the comparison of their optical rotation with 
the literature data. d Enantiomeric excess was determined by chiral GC or HPLC. e The solvent was CH2Cl2. 
f19% of di[1-(2-methoxy-phenyl)-ethyl]ether (47) was also isolated as a 55:45 diastereoisomeric mixture. g 
42% of di(1-phenyl-1-buten-3-yl)ether (48) was also isolated as a 1:1 diastereoisomeric mixture.  
 
 No reduction was observed with quinoline (R)-26 (Table 3, entry 1), presumably due to 
the steric constraints in the frontal part,26 imposed by the quinoline moiety, mirroring the 
behaviour of the pyridine analogue 17 substituted at the 6-position (Table 1, entry 20). The 3-
isoquinoline catalyst (R)-27 was approximately as efficient as the parent pyridine catalyst 16 
(Table 3, entry 2). A real improvement was attained with the 1-isoquinoline catalyst (S)-28 
(entries 3 and 4). The enhanced reactivity of 1-isoquinoline (S)-28 allowed to reduce the 
catalyst loading to 10 mol% with no adverse effect on enantioselectivity (Table 3, entry 5). This 
trend was consistent across a range of aromatic ketones (entries 6-11) with the highest 
enantioselectivity of 94% ee attained for the reduction of 2-acetylnaphthalene 1d (entry 7). 
Similarly to the results obtained with the pyridine analogue 16, 2-fluoroacetophenone 1i was 
reduced with lower selectivity (entry 11), whereas the aliphatic ketone 1l afforded a racemic 
product (entry 12). Reduction of benzylidene acetone 1m gave solely the product of 1,2-
addition, albeit in low enantioselectivity (entry 13). Furthermore, the reaction was 
accompanied by dimerisation of the resulting alcohol to give a mixture of diastereoisomeric 
ethers 48 (entry 13). Formation of ethers 47, though in smaller quantities, was also observed 
for the reduction of 1g (entry 10). 
Asymmetric reduction of ketimines with trichlorosilane. Significantly, 2-pyridyl 
oxazolines were also found to be active in the reduction of N-aryl ketimines.12 Preliminary 
results demonstrated that the pyridine-derived catalyst 16 (Table 4, entry 1) promoted the 
reduction of ketimine 2a derived from acetophenone with good yield and moderate 
enantioselectivity. The asymmetric induction was improved dramatically by employing the 
isoquinoline-derived catalyst (S)-28. The optimal conditions mirrored those identified for the 
reduction of ketones: chloroform emerged as the best solvent (compare entries 2-5), while 
running the reaction at -20 oC provided a good balance between reactivity and 
enantioselectivity. The enantioselectivity remained consistently high for a range of imines 
including heterocyclic substrates (entries 7-20). Significantly, even the pyridine-derived 
substrates 2k and 2l, notoriously known to be difficult to reduce enantioselectively,8g were 
efficiently reduced by employing (S)-28 (entries 16, 17). Reduction of imines 2m-2o derived 
from α-chloroketones proceeded in high enantioselectivity to afford the respective 
chloroamines 4m-4o (entries 18-20), which serve as precursor in the synthesis of terminal 
aziridines showing pesticide activity.8d  
The sense of asymmetric induction for the reaction of imines is similar to that observed in the 
case of ketones, so that a similar mechanism can be envisaged. The coordination of 
trichlorosilane to the nitrogen of the imine is unlikely, as this would create a very crowded 
environment. Hence, a hydrogen-bonding interaction with the catalyst, similar to structure C 
shown in Scheme 8, with the C=N–R3 group of the imine 2 in place of the C=O group, can be 
envisioned. However, in the absence of comprehensive kinetic and computational data we are 
currently unable to provide a more detailed mechanistic picture.  
 
Table 4: Reduction of Ketimines 2 with Trichlorosilane Catalyzed by (S)-28.a 
R1 R2
N
R1 R2
HN
2 4
*
−20 oC, 24 h
solvent
R3 R3Cl3SiH
(S)-28 (20 mol%)
 
entry imine R1, R2, R3 solvent 4, yield (%)b 
4, ee 
(%)c,d 
1e 2a Ph, Me, Ph CHCl3 94 54 
2 2a Ph, Me, Ph CHCl3 65 87 
3 2a Ph, Me, Ph MeCNf 50 34 
4 2a Ph, Me, Ph THFf 77 65 
5 2a Ph, Me, Ph Toluenef 27 79 
6 2a Ph, Me, Ph CH2Cl2f 34 82 
7 2b Ph, Me, PMP CHCl3 60 85 
8 2c Ph, Et, PMP CHCl3 90 79 
9 2d Naphth, Me, Ph CHCl3 67 87(98g) 
10 2e Naphth, Me, PMP CHCl3 67 86 
11 2f 4-CF3-C6H4, Me, PMP CHCl3 65 87 
12 2g 4-MeO-C6H4, Me, PMP CHCl3 51 87 
13 2h 2-furyl, Me, PMP CHCl3 73 55 
14 2i 2-benzofuryl, Me, PMP CHCl3 77 75 
15 2j 2-thienyl, Me, PMP CHCl3 77 60 
16 2k 4-pyridyl, Me, PMP CHCl3 70 82 
17 2l 2-pyridyl, Me, PMP CHCl3 88 79 
18 2m C6H5, CH2Cl, PMP CHCl3 90 88 
19 2n 4-Cl-C6H5, CH2Cl, PMP CHCl3 47 88 
20 2o 4-F-C6H5, CH2Cl, PMP CHCl3 70 89 
a The reactions were carried out on 0.4 mmol scale with 2.0 equiv. of HSiCl3 in CHCl3 in the presence of 
catalyst (S)-28 (20 mol%) at -20 oC for 24 h (unless stated otherwise). b Isolated yield (product pure by 
1H NMR). c Amines 5 were of (R)-configuration (except for entries 1, 12, 13) as revealed by the 
comparison of their optical rotation and their HPLC retention times with the literature data. d 
Enantiomeric excess was determined by HPLC using Chiracel OD-H, IB or AD columns. e Catalyst (R)-16 
was used. f The reaction time was 12 h. g After one recrystallization from methanol. 
 
In conclusion: We have developed a new family of Lewis-basic 2-pyridyl oxazolines, which can 
act as efficient organocatalysts for the enantioselective reduction of prochiral aromatic ketones 
and ketimines with trichlorosilane, a readily available and inexpensive reagent. 1-Isoquinoline 
derivative 28 was identified as the most efficient catalyst of the series capable of delivering 
high enantioselectivities in the reduction of both ketones (up to 94% ee) and ketimines (up to 
89% ee) and we propose to name it “Angusoline” in apreciation of the contribution made by 
one of us (A.J.P.S.L.). 
 
 
 
Experimental Section 
General Methods  
All reactions unless otherwise stated were run under an inert atmosphere in oven dried 
glassware. Room temperature refers to ambient room temperature (20-22˚C), 0˚C refers to an 
ice slush bath.  Heated experiments were conducted using thermostatically controlled oil baths. 
Reactions were monitored by thin layer chromatography (TLC) using aluminium backed silica 
gel 60 (F254) plates, visualised using UV254 nm and potassium permanganate, phosphomolybdic 
acid or Dragendorf dips as appropriate. Flash chromatography was carried out routinely using 
60 Å silica gel (Fischer). Melting points were determined on a Kofler block and are uncorrected. 
Optical rotations were recorded at 25 °C unless otherwise indicated with an error of <±0.1. The 
[α]D values are given in 10-1 deg cm2 g-1. The NMR spectra were recorded for CDCl3 solutions, 1H 
at 400 MHz and 13C at 100.6 MHz with chloroform-d1 (δ 7.26, 1H; δ 77.0, 13C) as an internal 
standard unless otherwise indicated. Coupling patterns are designated as follows: s - singlet, d - 
doublet, t - triplet, dd - doublet of doublets, ddd - doublet of doublet of doublets, tt - triplet of 
triplets, hept - heptet, m - multiplet, br - broad. Various 2D techniques and DEPT experiments 
were used to establish the structures and to assign the signals. The IR spectra were recorded 
for a thin film between NaCl plates, in a solid by the Golden Gate technique, or as a KBr disc. 
The mass spectra (EI and/or CI) were measured on a high resolution, dual sector mass 
spectrometer using direct inlet and the lowest temperature enabling evaporation. Enantiomeric 
excess was determined by GC (Supelco β-DEXTM 120 fused capillary column, 30 m × 0.25 mm 
×0.25 μm film thickness) or HPLC analysis as specified. 
Materials  
All solvents for the reactions were of reagent grade and were dried and distilled under argon or 
nitrogen immediately before use as follows: tetrahydrofuran, diethyl ether and toluene from 
sodium/benzophenone, dichloromethane from calcium hydride, chloroform from phosphorous 
pentoxide, methanol from magnesium turnings. Petroleum ether refers to the fraction boiling 
in the range 40-60 °C. Yields are given for isolated products showing one spot on a TLC plate 
and no impurities detectable in the NMR spectrum. The identity of the products prepared by 
different methods was checked by comparison of their NMR spectra. Imines 2a-2o are known 
compounds and were prepared according to literature method.8g Oxazolines 14-16,12,14 2614 
and 2714 are known compounds. 
 
General Procedure for the Asymmetric Reduction of Ketones 1 with Trichlorosilane. 
Trichlorosilane (86 μL, 0.84 mmol, 2.1 equiv) was slowly added dropwise to a solution of the 
catalyst (21.9 mg, 0.08 mmol or 11.0 mg, 0.04 mmol) and the ketone (0.40 mmol, 1.0 eq) in 
CHCl3 (2 mL) at –20 ˚C. The reaction mixture was stirred at -20 ˚C for 24 h, after which time 
saturated aqueous NaHCO3 (1 mL) was added to quench the reaction. The mixture was 
extracted with CH2Cl2 (3 × 10 mL) and the combined organic extracts were dried over MgSO4. 
Concentration in vacuo followed by flash chromatography on silica gel with CH2Cl2 afforded sec-
alcohols 3a, 3b, 3d-3i, 3k, 3l. Configuration of alcohols 3a, 3b, 3d-3i, 3k was established by 
comparison of their optical rotations and their HPLC (Chiracel OD-H or AD columns) and GC 
retention times with the literature data and with the behaviour of authentic samples. 
Enantioenriched alcohols 3a, 3b, 3d-3i, 3k, 3l were described by us previously,12 alcohol 3m is 
also a known compound.27 
 
General Procedure for the Asymmetric Reduction of Imines 2 with Trichlorosilane. 
Trichlorosilane (82 μL, 0.80 mmol, 2.0 eq) was slowly added dropwise to a solution of the 
catalyst (21.9 mg, 0.08 mmol) and the imine (0.40 mmol, 1.0 eq) in CHCl3 (2 mL) at –20 ˚C. The 
reaction mixture was stirred at -20 ˚C for 24 h, after which time saturated aqueous NaHCO3 (1 
mL) was added to quench the reaction. The mixture was extracted with CH2Cl2 (3 × 10 mL) and 
the combined organic extracts were dried over MgSO4. Concentration in vacuo followed by 
flash chromatography on silica gel afforded amines 4a-4o. Configuration of the amines (where 
known) was established by comparison of their optical rotations and their HPLC (Chiracel OD-H, 
IB or AD columns) retention times with the literature data and with the behaviour of authentic 
samples. All amines 4a-4o are known compounds.8d,8g 
 
(S)-(+)-2-(6’-Phenyl-2’-pyridyl)-5-phenyl-1,3-oxazoline (S)-(+)-(17). Sodium methoxide 
(20 mg, 0.37 mmol, 0.13 equiv) was added to a solution of 6-phenyl-2-cyanopyridine 29b28 (500 
mg, 2.78 mmol, 1.0 equiv) in MeOH (15 mL) and the reaction mixture was stirred at room 
temperature overnight. The reaction was then quenched with glacial acetic acid (2 drops) and 
the mixture was concentrated in vacuo.  Warm ether was then added and the mixture was 
filtered. The filtrate was concentrated under reduced pressure and the residue was dissolved in 
chlorobenzene (4 mL).  (S)-Aminoalcohol (+)-31d was then added, followed by conc. HCl (1 
drop). The mixture was stirred at 80˚C for 3 days, with argon gas bubbled through the solution.  
Concentration in vacuo followed by purification via flash chromatography on silica gel, eluting 
with a hexane-ethyl acetate-triethylamine mixture (2:1:0.03) gave the pyridine oxazoline (S)-17 
(523 mg, 63%): mp 60-62 ˚C (CH2Cl2); [α]D +104.6 (c 1.1, CHCl3); IR (KBr) ν 1637 (C=N), 2873, 
2932 (CH/CH2), 3032, 3060 (Ar-H) cm-1; 1H NMR (400 MHz, CDCl3) δH 4.03 (dd, J = 15.2, 8.2 Hz, 
1H), 4.50 (dd, J = 15.2, 10.2 Hz, 1H), 5.69 (dd, J = 10.2, 8.2 Hz, 1H), 7.24-7.43 (m, 8H), 7.77-7.79 
(m, 2H), 7.84-7.94 (m, 1H), 8.00-8.03 (m, 2H); 13C NMR (100 MHz, CDCl3) δC 63.8 (CH2), 82.1 
(CH), 122.7 (CH), 122.8 (CH), 126.3 (2 × CH), 127.6 (2 × CH), 128.8 (CH), 129.1 (2 × CH), 129.2 (2 
× CH), 129.7 (CH), 137.8 (CH), 139.0 (C), 141.2 (C), 147.0 (C), 158.1 (C), 163.9 (C); EI MS m/z (%) 
300 (M+•, 65), 193 (100), 154 (15), 127 (16), 118 (12), 77 (8); HRMS (EI) 300.1260 (C20H16N2O 
requires 300.1263). 
 
(S)-(+)-2-(4’-Methoxy-2’-pyridyl)-5-phenyl-1,3-oxazoline (S)-(+)-(18). Sodium methoxide 
(18 mg, 0.33 mmol, 0.12 equiv) was added to a solution of 4-methoxy-2-cyanopyridine 29c (361 
mg, 2.69 mmol, 1.0 equiv) in MeOH (15 mL) and the reaction mixture was stirred at room 
temperature overnight. The reaction was then quenched with glacial acetic acid (2 drops) and 
the mixture was concentrated in vacuo.  Warm ether was then added and the mixture was 
filtered.  The filtrate was concentrated under reduced pressure and the residue was dissolved 
in chlorobenzene (4 mL).  (S)-(+)-Amino alcohol (S)-31d (392 mg, 2.86 mmol, 1.1 equiv) was 
then added, followed by conc. HCl (1 drop).  The reaction mixture was stirred at 80 ˚C for 3 
days, with argon gas bubbled through the solution. Concentration in vacuo, followed by 
purification via flash chromatography on silica gel (ethyl acetate-methanol, 25:1), gave 
pyridine-oxazoline (S)-18 (215mg, 31%) as a clear oil: [α]D +74.9 (c 0.9, CHCl3); IR (neat) ν 2873, 
2939 (CH/CH2/CH3), 3030, 3063 (Ar-H) cm-1; 1H NMR (400 MHz, CDCl3) δH  3.84 (s, 3H), 4.01 (dd, 
J = 15.2, 8.2 Hz, 1H), 4.47 (dd, J = 15.2, 10.2 Hz, 1H), 5.67 (dd, J = 10.2, 8.3 Hz, 1H), 6.85 (dd, J = 
5.7, 2.6 Hz, 1H), 7.24-7.31 (m, 5H), 7.55 (d, J = 2.6 Hz, 1H), 8.46 (d, J = 5.7 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δC 55.9 (CH3), 63.5 (CH2), 82.3 (CH), 109.8 (CH), 112.7 (CH), 126.4 (2 × CH), 128.2 
(CH), 129.2 (2 × CH), 140.9 (C), 148.6 (C), 151.4 (C), 163.7 (C), 166.5 (C); EI MS m/z (%) 254 (M+•, 
100), 195 (7), 166 (8), 148 (95), 108 (72), 84 (65), 77 (9), 47 (11); HRMS (EI) 254.1054 (C15H14 
N2O2 requires 254.1055).  
 
(S)-(–)-2-(2’-Pyridyl)-5-phenyl-1,3-oxazoline (S)-(–)-(19). Adapting the protocol of 
Brunner14 amino alcohol (−)-31d (570 mg, 4.17 mmol, 1.0 equiv) was added to a solution of 
methyl pyridine-2-carboxyimidate 30a (567 mg, 4.17 mmol, 1.0 equiv) in chlorobenzene (5 mL).  
A drop of conc. HCl was added and the reaction mixture was stirred at 80 ˚C overnight with 
argon bubbled through the solvent.  The solvent was then removed and purification via column 
chromatography (ethyl acetate-methanol, 40:1) afforded (−)-19 (812 mg, 82%) as a clear oil: 
[α]D –171.5 (c 1.07, CHCl3); IR ν (KBr) 1673 (C=N); 2869, 2930, 2975 (CH/CH2/CH3), 3027 (aryl-H) 
cm-1; 1H NMR (400 MHz, CDCl3) δH 1.89 (s, 3H), 4.22 (d, J = 14.8 Hz, 1H), 4.23 (d, J = 14.8 Hz, 1H), 
7.29-7.45 (m, 6H), 7.84 (td, J = 8.0, 2.0 Hz, 1H), 8.13 (d, J = 7.6 Hz, 1H), 8.80 (d, J = 4.8 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δC 28.1 (CH3), 69.1 (CH), 87.7 (C), 123.8 (CH), 124.3 (2 × CH), 125.5 
(CH), 127.4 (CH), 128.5 (2 × CH), 136.6 (CH), 145.1 (C), 146.9 (C), 149.9 (CH), 162.3 (C); EI MS 
m/z (%) 238 (M+•, 20), 118 (100), 91 (15), 78 (80), 77 (10), 51 (10); HRMS (EI) 238.1107 
(C15H14N2O requires 238.1106). 
 
(±)-2-(2’-Pyridyl)-5-(4’’-Trifluoromethylphenyl)-1,3-oxazoline (±)-(20). Adapting the 
procedure of Bruner,14 2-amino-1-phenylethanol (±)-31e (754 mg, 3.68 mmol, 1.0 equiv) was 
added to a solution of imidate 30a (500 mg, 3.68 mmol, 1.0 equiv) in chlorobenzene (5 mL).  A 
drop of conc. HCl was added and the reaction mixture was stirred at 80 ˚C overnight with argon 
bubbled through the solvent. The solvent was then removed in vacuo and purification of the 
residue via column chromatography on silica gel (ethyl acetate-triethylamine, 10:0.1) afforded 
oxazoline 20 (809 mg, 75%) as a yellow solid: mp 68-70 ˚C (CH2Cl2); IR ν (KBr) 1643 (C=N), 2867, 
2963 (CH/CH2) cm-1; 1H NMR (400 MHz, CDCl3) δH 3.98 (dd, J = 15.4, 8.0 Hz, 1H), 4.53 (dd, J = 
15.4, 10.4 Hz, 1H), 5.73 (dd, J = 10.4, 8.0 Hz, 1H), 7.37 (ddd, J = 7.6, 4.8, 0.8 Hz, 1H), 7.43 (d, J = 
8.0 Hz, 2H), 7.57 (d, J = 8.0 Hz, 2H), 7.76 (td, J = 8.0, 2.0 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 8.69 
(dd, J = 4.8, 0.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δC  63.3 (CH2), 80.9 (CH), 124.0 (q, 1JCF = 246 
Hz, [CF3], 124.0 (2 × CH), 125.8 (C), 125.9 (CH), 125.9 (CH), 126.1 (2 × CH), 130.6 (q, 2JCF = 32 Hz, 
[C]), 136.8 (CH), 144.6 (C), 146.3 (C), 150.0 (CH); EI MS m/z (%) 292 (M+•, 75), 273 (5), 186 (10), 
159 (7), 118 (100), 106 (7), 78 (98), 51 (10); HRMS (EI) 292.0822 (C15H11F3N2O requires 
292.0823).  
 
(+)-2-(2’-Pyridyl)-5-tert-butyl-1,3-oxazoline (+)-(21). Adapting the protocol of 
Brunner,14 1-amino-3,3-dimethylbutan-2-ol (±)-31f (430 mg, 3.68 mmol, 1.0 equiv) was added 
to a solution of methyl pyridine-2-carboxyimidate (500 mg, 3.68 mmol, 1.0 equiv) in 
chlorobenzene (5 mL).  A drop of conc. HCl was added and the reaction mixture was stirred at 
80 ˚C overnight with argon bubbled through the solvent.  The solvent was then removed in 
vacuo and purification of the residue via column chromatography on silica gel (ethyl acetate-
methanol, 20:1) afforded oxazoline (±)-21 (671mg, 89%) white solid: mp 73-75 ˚C (CH2Cl2);; IR 
(KBr) ν 1644 (C=N), 2869, 2958 (CH/CH2/CH3), 3066 (aryl-H) cm-1; 1H NMR (400 MHz, CDCl3) δH 
0.91 (s, 9H), 3.81 (dd, J = 15.2, 8.0 Hz, 1H), 3.98 (dd, J = 15.2, 10.4 Hz, 1H), 4.44 (dd, J = 10.4, 8.0 
Hz, 1H), 7.31 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 7.70 (td, J = 7.6, 1.6 Hz, 1H), 7.92 (d, J = 7.6 Hz, 1H), 
8.66 (dd, 4.0, 0.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δC  24.8 (3 × CH3), 34.0 (C), 55.9 (CH2), 88.4 
(CH), 123.6 (CH), 125.4 (CH), 136.6 (CH), 146.9 (C), 149.9 (CH), 163.5 (C); EI MS m/z (%) 204 
(M+•, 15), 147 (100), 119 (35), 92 (50), 78 (55), 51 (10); HRMS (EI) 204.1261 (C12H16N2O requires 
204.1263). The racemate was resolved by preparative chiral HPLC on a Chiralpak AD column 
(Heptane−2-Propanol, 98:2, 1mL/min) to give (+)-21: [α]D +24.0 (c 0.9, CHCl3) and the respective 
(−)-21. 
 
(R)-(+)-2-(2’-Pyridyl)-1-methyl-4-phenyl-imidazoline (R)-(+)-(22). A solution of diamine 
(R)-35 (500 mg, 3.7 mmol, 1.0 equiv) in PhCl (5 mL) was added to a solution of imidate 30a (500 
mg, 3.7 mmol, 1.0 equiv) in chlorobenzene (10 mL). The reaction mixture was stirred at 80 ˚C 
overnight with argon bubbling through the solution. The solvent was then removed from the 
resultant dark brown paste under reduced pressure and the crude product was purified via 
flash chromatography on silica gel (ethyl acetate-methanol-triethylamine, 9:1:0.1) to give 
imidazoline (R)-22 (732 mg, 84%) as a yellow oil: [α]D +11.9 (c 1.0, CHCl3); IR (KBr) ν 1522, 1670 
(aryl ring), 2797, 2848, 2937 (CH/CH2/CH3), 3029, 3059 (Ar-H) cm-1; 1H NMR (400 MHz, CDCl3) δH 
3.12 (s, 3H), 3.40 (t, J = 9.4, 1H), 4.01 (dd, J = 10.9, 9.4Hz, 1H), 5.21 (dd, J = 10.7, 9.7Hz, 1H), 
7.28-7.29 (m, 1H), 7.35-7.40 (m, 5H), 7.79 (td, J = 7.6, 1.6Hz, 1H), 7.91 (dt, J = 7.6, 0.8Hz, 1H), 
8.69 (dd, J = 4.8, 1.6, 0.8Hz, 1H); 13C NMR (100 MHz, CDCl3) δC 36.2 (CH3), 62.5 (CH2), 68.0 (CH), 
124.9 (CH), 125.0 (CH), 127.2 (2 × CH), 127.5 (CH), 128.9 (2 × CH), 137.1 (CH), 144.5 (C), 149.0 
(CH), 150.9 (C), 165.5 (C); CI MS m/z (%) 238 ([M+H]+, 100); HRMS (CI) 238.1341 (C15H16N3 
requires 238.1344). 
 (R)-(–)-2-(2’-Pyridyl)-1-methyl-5-phenyl-imidazoline (R)-(–)-(23). Diamine (R)-38 (926 
mg, 6.13 mmol, 1.0 equiv) was added to a solution of imidate 30a (840 mg, 6.13 mmol, 1.0 
equiv) in chlorobenzene (2.0 mL) and the reaction mixture was stirred at 60 ˚C overnight with 
argon bubbling through the solution. The solvent was then removed from the resultant dark 
brown paste under reduced pressure and the crude product was purified via flash 
chromatography on silica gel (ethyl acetate) to give imidazoline (R)-23 (906 mg, 62%) as a 
yellow oil: [α]D –86.2 (c 0.67, CHCl3); IR (KBr) ν 1671, 1590, 1495 (aryl ring), 2858, 2920 
(CH/CH2CH3), 3029, 3060 (Ar-H) cm-1; 1H NMR (400 MHz, CDCl3) δH 2.88 (s, 3H), 3.67 (dd, J = 
14.8, 10.8 Hz, 1H), 4.29 (dd, J = 14.8, 10.8 Hz, 1H), 4.53 (t, J = 10.8 Hz, 1H), 7.22-7.34 (m, 6H), 
7.72 (td, 7.6, 0.4 Hz, 1H), 7.88 (d, J = 7.6 Hz, 1H), 8.60 (d, J = 4.4 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δC 34.2 (CH3), 62.7 (CH2), 70.4 (CH), 124.6 (2 × CH), 127.2 (2 × CH), 127.8 (C), 128.8 (2 × 
CH), 136.7 (CH), 147.5 (C), 148.7 (CH), 150.5 (C), 165.1 (C); EI MS m/z (%) 237 (M+•, 75), 236 
(10), 222 (6), 207 (4), 160 (15), 133 (100), 118 (50), 78 (80), 77 (12), 51 (10); HRMS (EI) 237.1268 
(C15H15N3 requires 237.1266). 
 
(S)-(–)-2-(2’-Pyridyl)-5-phenyl-thiazoline (S)-(–)-(24). Mesyl chloride (0.57 mL, 7.01 
mmol) and triethylamine (2.15 mL, 14.3 mmol) were added to a solution of (S)-43 (1.29 g, 4.99 
mmol) in THF (15 mL) at 0 oC and the reaction was allowed to stir at room temperature for 48 h. 
Water (10 mL) was then added and the mixture was extracted with CH2Cl2 (3 x 20 mL). The 
organic layer was washed with water (2 × 20 mL) and dried over MgSO4 and the solvent 
removed in vacuo. The crude solid was purified by chromatography on a column of silica gel (20 
g) with a mixture of petroleum ether and AcOEt (1:1) to afford an off white solid, which was 
recrystallised from EtOH to afford thiazoline (S)-(−)-24 as a white crystalline solid (0.98 g, 82%); 
mp 105–106 oC; [α]D–77.50 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δH 4.60 (dd, J = 16.4, 5.8 Hz, 
1H), 4.82 (, dd, J = 16.4, 9.1 Hz, 1H), 4.99 (, dd, J = 9.1, 5.8 Hz, 1H), 7.17 – 7.33 (m, 6H), 7.73 (dt, 
J = 7.8, 1.8 Hz, 1H), 8.05 (dt, J = 7.8, 1.0 Hz, 1H), 8.60 (ddd, J = 4.8, 1.0, 0.8 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δC 53.5 (CH), 73.9 (CH2), 121.6 (CH), 125.5 (CH), 127.2 (CH), 127.7 (CH), 128.9 
(CH), 136.6 (CH), 142.2 (C), 149.4 (CH), 151.2 (C), 170.2 (C); MS EI+ m/z (%) 240.1 (M+, 100), 
118.0 (49), 78.0 (74), 51.0 (20); HRMS (EI) 240.0721 (C14H12N2S requires 240.0718). 
 
(S)-(–)-2-(1’-Isoquinolyl)-5-phenyl-thiazoline (S)-(–)-(25). A solution of amide (R)-44 
(253 mg, 0.71 mmol) and Lawesson’s reagent (344 mg, 0.85 mmol) in toluene (20 mL) was 
heated at 85 oC overnight. The reaction mixture was then allowed to cool to room temperature, 
aqueous 2M HCl (20 mL) was added, and the precipitate was removed by filtration. After 
separation of the organic layer, the aqueous phase was extracted with CH2Cl2 (3 x 30 mL) and 
the combined organic phases were washed with water (3 x 15 ml) and dried over MgSO4. The 
solvent was then evaporated in vacuo and the residue was purified by chromatography on a 
column of silica gel with a mixture of petroleum ether and AcOEt (5:1) to afford (S)-(−)-25 as a 
yellow oil (152 mg, 74%): [α]D -22.9 (c = 1.0, CHCl3); 1H NMR (400MHz, CDCl3) δH 4.78 (1H, dd, J = 
4.3, 15.2 Hz, 2-H), 4.83 – 4.89 (1H, m, 1α-H), 5.02 – 5.06 (1H, m, 1β-H), 7.17 (m, 1H), 7.21 – 7.25 
(m, 2H), 7.33 – 7.35 (m, 2H), 7.59 – 7.66 (m, 3H), 7.89  - 7.97 (m, 1H), 8.52 (d, J = 5.6 Hz, 1H), 
9.42 (dd, J = 1.5, 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δC 52.2 (CH, C-2), 75.2 (CH2, C-1), 123.2 
(CH), 126.4 (C-3), 127.0 (CH), 127.2 (CH), 127.5 (CH), 127.6 (CH), 128.9 (CH), 130.4 (CH), 136.9 
(C-14), 141.5 (CH), 142.4 (CH), 149.2 (C-9), 168.1 (C-8), 170.9 (C-7); MS EI m/z (%) 290.1 (M+, 
100), 186.0 (44), 128.0 (92), 91.0 (28); HRMS (EI) 290.0878 (C18H14N2S requires 290.0879). 
 
(S)-(+)-2-(1’-Isoquinolinyl)-5-phenyl-1,3-oxazoline (S)-(+)-(28). Triethylamine (2.5 mL, 
17.78 mmol, 5.2 equiv) was added to a solution of (R)-40 (1.00 g, 3.42 mmol, 1.0 equiv) in 
CH2Cl2 (65 mL). The mixture was then cooled to 0 ˚C and a solution of methanesulfonyl chloride 
(0.62 mL, 7.87 mmol, 2.3 equiv) in CH2Cl2 (10 mL) was added dropwise over 15 min. The 
reaction vessel was then allowed to attain room temperature and stirred overnight. The 
reaction mixture was poured onto crushed ice, the aqueous layer was extracted with CH2Cl2, 
and the combined organic phase was washed with 5% aqueous HCl (3 × 40 mL), water (1 × 40 
mL), saturated aqueous NaHCO3  (3 × 40 mL), and brine  (1 × 40 mL) and dried over MgSO4. 
Concentration in vacuo then afforded a residue, which was purified via column 
chromatography on silica gel (petroleum ether-ethyl acetate, 1:1) to give 28 (0.89 g, 95%) as a 
white solid: mp 78-80 °C (CH2Cl2); [α]D +83.5 (c 0.5, CHCl3); IR (KBr) 700, 759, 838 (aryl), 1645 
(C=N), 2866, 2931 (CH/CH2), 3064 (aryl-H) cm-1; 1H NMR (400 MHz, CDCl3) δH 4.29 (dd, J = 15.2, 
8.0 Hz, 1H), 4.74 (dd, J = 15.2, 10.4 Hz, 1H), 5.84 (dd, J = 10.4, 8.0 Hz, 1H), 7.35-7.55 (m, 5H), 
7.71-7.80 (m, 2H), 7.83 (d, J = 5.6 Hz, 1H), 7.92 (d, J = 7.6 Hz, 1H), 8.71 (d, J = 5.6 Hz, 1H), 9.28 
(d, J = 8.8 Hz, 1H); 13C NMR (100MHz, CDCl3) δC 63.9 (CH2), 80.7 (CH), 123.5 (CH), 126.1 (2 × CH), 
127.2 (CH), 127.3 (CH), 127.4 (C), 128.4 (CH), 128.6 (CH), 128.9 (2 × CH), 130.5 (CH), 136.8 (C), 
140.7 (C), 141.9 (CH), 146.3 (C), 162.7 (C); EI MS m/z (%) 274 (M+•, 65), 168 (70), 128 (100), 101 
(15), 82 (35), 77 (10), 47 (5); HRMS (EI) 274.1105 (C18H14N2O requires 274.1106). 
 
2-Cyano-4-methoxy-pyridine (29c). Adapting the method of Fife,28a Me3SiCN (1.55 mL, 
1.15 g, 11.7 mmol, 1.25 equiv) was added to a solution of 4-methoxypyridine-N-oxide (1.17 g, 
9.36 mmol, 1.0 equiv) in CH2Cl2 (100 mL) at room temperature. A solution of 
dimethylcarbamoyl chloride (0.73 mL, 1.26 g, 11.7 mmol, 1.25 equiv) in CH2Cl2 (20 mL) was then 
added dropwise over 30 min and the reaction mixture was stirred at room temperature for 6 
days. Satd. Na2CO3 (aq) (50 mL) was then added and the mixture was stirred for a further 10 
min. The organic phase was then separated and the aqueous layer was extracted with CH2Cl2 (3 
× 50 mL).  The combined organic extracts were dried over MgSO4 and the solvent was removed 
in vacuo to give the crude product, which was purified via column chromatography on silica gel 
(ethyl acetate) to give 29c (932 mg, 74%) as a pale yellow solid: mp 115-117 ˚C (CH2Cl2); IR (KBr) 
ν 1528, 1586, 1657 (aryl ring), 2888, 2929, 2954 (CH3), 2996 (Ar-H) cm-1; 1H NMR (400 MHz, 
CDCl3) δH 3.84 (s, 3H), 6.93 (dd, J = 5.6, 2.4 Hz, 1H), 7.15 (d, J = 2.4 Hz, 1H), 8.44 (d, J = 5.6 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δC 56.2 (CH3), 113.1 (CH), 115.8 (CH), 117.5 (C), 135.5 (C), 152.7 
(CH), 166.3 (C); EI MS m/z (%) 134 (M+•, 100), 119 (5), 104 (50), 104 (50), 83 (20), 77 (25), 64 
(10), 51 (10), 50 (9); HRMS (EI) 134.0479 (C7H6N2O requires 134.0480). 
 
1-Amino-2-phenylpropan-2-ol (31d).29 Adapting the protocol of Fleming,16 Me3SiCN (6.1 
mL, 45.0 mmol, 1.1 equiv) and anhydrous ZnI2 (80 mg, 0.25 mmol, 0.6 mol%) were added to a 
Schlenk tube containing acetophenone 32a (4.85 mL, 41.6 mmol, 1.0 equiv) and the mixture 
was stirred at 50 ˚C for 16 h.  The neat reaction mixture was then diluted with THF (200 mL) and 
added via cannula to a suspension of LiAlH4 (4.75 g, 125 mmol, 3.0 equiv) in THF (200 mL). After 
heating at reflux for 3 h the reaction was quenched with Na2SO4⋅10H2O and filtered through a 
pad of celite (eluting with ether).  Concentration of the filtrate in vacuo afforded 31d (3.90 g, 
62%) as a clear oil: 1H NMR (400 MHz, CDCl3) δH 1.34 (s, 3H), 2.65 (d, J = 12.8 Hz, 1H), 2.95 (d, J = 
12.8 Hz, 1H), 7.25-7.29 (m, 1H), 7.34 (t, J = 8.0 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H); 13C NMR (100 
MHz, CDCl3) δC 27.8 (CH3), 52.7 (CH2), 73.4 (C), 125.1 (2 × CH), 126.7 (CH), 128.2 (2 × CH), 146.5 
(C); CI MS m/z (%) 152 ([M+H]+, 100), 134 (64), 121 (11), 97 (4), 71 (7); HRMS (CI) 152.1078 
(C9H14NO requires 152.1075), in agreement with the literature.29 
Resolution: The resolution of 31d was carried out by recrystalising racemic 31d (3.90 g, 25.8 
mmol, 1.0 equiv) and (+)-mandelic acid (3.93 g, 25.8 mmol, 1.0 equiv) from hot ethanol three 
times.  The resultant salt was then basified with 2M NaOH (30 mL) and extracted with ether (2 
× 30 mL), dried over MgSO4 and concentrated in vacuo to give (−)-31d (688 mg, 35%): [α]D -13.6 
(c 1.2, CHCl3). 
GC Analysis: A portion of (−)-31d (50 mg) in CH2Cl2 (1 mL) was treated with TFAA (1 mL) and 
stirred for 30 min.  After concentration in vacuo the crude residue was passed through a plug 
column of silica gel (ethyl acetate) to provide a chiral GC sample: Chiral GC (β-DEXTM); carrier 
gas, He (flow 2 mL/min); injection temp, 200 ˚C; column temp: initial temperature, 80 ˚C; rate, 
1.5 ˚C/min; final temperature, 200 ˚C, t(+) 48.62 min, t(-) 48.72 min, showed 92% ee. 
 
2-Amino-1-(4’-trifluoromethylphenyl)-ethanol (31e). Adapting the protocol of 
Flemming,16 Me3SiCN (1.37 mL, 10.3 mmol, 1.4 equiv) and anhydrous ZnI2 (15 mg, 0.05 mmol, 
0.6 mol%) were added to a Schlenk tube containing 4-trifluomethyl benzaldehyde (1.0 mL, 7.33 
mmol, 1.0 equiv) and the mixture was stirred at 50 ˚C for 16 h.  The neat reaction mixture was 
then diluted with THF (150 mL) and added via cannula to a suspension of LiAlH4 (1.66 g, 43.8 
mmol, 3.0 equiv) in THF (100 mL).  After heating at reflux for 4 h the reaction was quenched 
with Na2SO4⋅10H2O and the mixture was filtered through a pad of celite (eluting with ether).  
Concentration in vacuo afforded 31e (1.32 g, 88 %) as a yellow solid: mp 70-72 ˚C; IR ν (KBr) 
1330 (C-O), 2923 (CH/CH2), 3095 (Ar-H) cm-1; 1H NMR (400 MHz, CDCl3) δH 2.53 (bs, 3H), 2.66-
2.71 (m, 1H), 2.89-2.92 (m, 1H), 4.61 (dd, J = 7.6, 3.6 Hz, 1H), 7.37 (d, J = 8.0 Hz, 2H), 7.51 (d, J = 
8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δC  48.0 (CH2), 72.2 (CH), 123.1 (q, 1JCF = 270 Hz, [CF3]), 
124.4 (2 × CH), 125.1 (2 × CH), 128.7 (q, 2JCF = 32 Hz, [C]), 145.6 (C); CI MS m/z (%) 206 ([M+H]+, 
100), 188 (10), 121 (1) 71 (2); HRMS (CI) 206.0791 (C9H11F3NO requires 206.0793). 
 1-Amino-3,3-dimethylbutan-2-ol (31f).30 Adapting the protocol of Fleming,16 Me3SiCN 
(4.33 mL, 32.5 mmol, 1.4 equiv) and anhydrous ZnI2 (40 mg, 0.125 mmol, 0.5 mol%) were added 
to a Schlenk tube containing pivaldehyde (2.57 mL, 23.2 mmol, 1.0 equiv) and the reaction 
mixture was stirred at 50 ˚C for 16 h. The neat reaction mixture was then diluted with THF (250 
mL) and added via cannula to a suspension of LiAlH4 (2.66 g, 70.0 mmol, 3.0 equiv) in THF (150 
mL). After heating at reflux for 3 h, the reaction was quenched with Na2SO4⋅10H2O and the 
mixture was filtered through a pad of celite (eluting with ether). The filtrate was concentrated 
by evaporation in vacuo to afford 31f (2.23g, 82%) as a yellow solid: mp 55-57˚C (CH2Cl2); IR 
(KBr) ν 2956 (CH/CH2/CH3), 3281 (N-H) cm-1; 1H NMR (400 MHz, CDCl3) δH 0.76 (s, 9H), 1.78 (bs, 
3H), 2.33 (dd, J = 12.4, 10.4 Hz, 1H), 2.77 (dd, J = 12.4, 2.8 Hz, 1H), 3.00 (dd, J = 10.4, 2.8 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δC 24.4 (3 × CH3), 32.4 (C), 41.1 (CH2), 78.1 (CH); CI MS m/z (%) 118 
([M+H]+, 100), 91 (2), 71 (2); HRMS (CI) 118.1230 (C6H16NO requires 118.1232), in agreement 
with the literature.30 
 
(R)-2-Amino-1-methylamino-2-phenylethane (R)-(35).31 A solution of (R)-3431 (5.17 g, 
32.0 mmol, 1.0 equiv) in THF (200 mL) was added to a suspension of LiAlH4 (6.0 g, 158.0 mmol, 
5.0 equiv) in THF (300 mL) at 0 ˚C and the reaction mixture was heated to reflux overnight. 
After quenching with Na2SO4⋅10H2O, the suspension was passed through a pad of celite, eluting 
with ether. The solvent was then removed in vacuo to give diamine (R)-35 (2.56 g, 53%) as a 
yellow oil: 1H NMR (400 MHz, CDCl3) δH 2.37 (s, 3H), 2.63-2.73 (m, 2H), 3.98 (dd, J = 7.8, 5.3 Hz, 
1H), 7.17-7.34 (m, 5H); 13C NMR (100 MHz, CDCl3) δC 36.8 (CH3), 55.8 (CH), 60.4 (CH2), 126.8 (2 × 
CH), 127.6 (CH), 128.9 (2 × CH), 145.1 (C), in accordance with the literature.31 
 
(R)-(–)-2(tert-Butylcarbamido)-2-phenylacetamide  (R)-(–)-(37). A solution of di-tert-
butyl carbonate (2.9 g, 13.3 mmol, 1.0 equiv) in THF (50 mL) was added to a solution of amine 
(R)-3632 (2.0 g, 13.3 mmol, 1.0 equiv) and NaHCO3 (1.5 g, 17.9 mmol, 1.3 equiv) in H2O (50 ml) 
and the reaction mixture was stirred at room temperature overnight. The volatile solvent was 
then removed under reduced pressure and the residue was extracted with CH2Cl2 (3 × 100 mL) 
and dried over MgSO4. Concentration in vacuo afforded (R)-37 as a white solid (2.39 g, 72%): 
mp 119-121 ˚C (CH2Cl2); [α]D –170.7 (c 0.3, CHCl3), IR (neat) ν 1685 (C=O), 2832, 2945, 2984 
(CH/CH3), 3055 (Ar-H);  1H NMR (400 MHz, CDCl3) δH 1.34 (s, 9H), 5.11 (s, 1H), 5.46 (s, 1H), 5.62 
(s, 1H), 5.71 (s, 1H), 7.24-7.32 (m, 5H); 13C NMR (100 MHz, CDCl3) δC 27.8 (CH), 28.7 (3 × CH3), 
58.8 (C), 127.7 (2 × CH), 128.9 (CH), 129.5 (2 × CH), 138.6 (C), 172.6 (C); CI MS m/z (%) 251 
([M+H]+, 38), 195 (100), 151 (15), 106 (5); HRMS (CI) 251.1398 (C13H19 N2O3 requires 251.1396). 
 
(R)-(–)-1-Amino-2-Methylmino-2-phenylethane (R)-(–)-(38).33 A solution of amide (R)-
37 (2.76 g, 11.0 mmol, 1.0 equiv) in THF (200 mL) was added to a suspension of LiAlH4 (2.5 g, 
66.0 mmol, 6.0 equiv) in THF (300 mL) at 0 ˚C and the reaction mixture was then heated to 
reflux overnight. After quenching with Na2SO4⋅10H2O, the suspension was passed through a pad 
of celite, eluting with ether. The solvent was then removed to give diamine (R)-38 (1.39 g, 84%) 
as a viscous oil: [α]D –31.2 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δH 2.21 (s, 3H), 2.70 (dd, J = 
12.8, 7.2 Hz, 1H), 2.79 (dd, J = 12.8, 5.6 Hz, 1H), 3.37 (dd, J = 6.8, 5.6 Hz, 1H), 7.13-7.26 (m, 5H) 
in accordance with the literature.33 
  
(R)-(–)-N-(2’-Hydroxy-2’-phenylethyl)-1-isoquinolinyl-carboxamide (R)-(–)-(40). Methyl 
chloroformate (1.56 mL, 19.82 mmol, 1.2 equiv) was added dropwise to a stirred solution of 1-
isoquinoline carboxylic acid 39 (2.86 g, 16.52 mmol, 1.0 equiv) and triethylamine (2.76 mL, 
19.82 mmol, 1.2 equiv) in anhydrous THF (80 mL) at 0 oC under an argon atmosphere and the 
solution was stirred at that temperature for 2 h. The precipitate was removed by filtration in 
vacuo and the filtrate was added dropwise to a solution of (R)-31c (2.72 g, 19.82 mmol, 1.2 
equiv) and triethylamine (2.76 mL, 19.82 mmol, 1.2 equiv) in anhydrous THF (80 mL) at 0 oC 
under an argon atmosphere and the mixture was allowed to attain room temperature and 
stirred overnight. The solvent was removed under reduced pressure and the residue was 
purified via column chromatography on silica gel (petroleum ether-ethyl acetate, 1:1) to afford 
40 (4.30 g, 89%) as a white amorphous solid: [α]D -78.6 (c = 0.5, CHCl3); 1H NMR (400 MHz, 
CDCl3) δH 3.48 (ddd, J1α,1β = 13.9 Hz, J1α,2 = 8.6 Hz, J1α,NH = 5.3 Hz, 1H), 3.85 (ddd, J1α,1β = 13.9 Hz, 
J1β,NH = 7.1 Hz, , J1β,2 = 3.3 Hz, 1H), 5.08 (dd, J1α,2 = 8.6 Hz, J1β,2 = 3.3 Hz, 1H), 7.15-7.26 (m, 3H), 
7.37 (d, J = 7.1 Hz, 2H), 7.49-7.57 (m, 2H), 7.59 (d, J = 5.3 Hz, 2H), 7.70 (d, J = 7.6 Hz, 1H), 8.17 
(d, J = 5.6 Hz, 1H), 8.67 (t, J = 5.8 Hz, 1H), 9.30 (d, J = 8.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δC 
47.9 (CH, 1-C), 74.2 (CH2, 2-C), 124.6 (CH), 125.9 (CH), 126.9 (CH), 127.1 (C, 3-C), 127.7 (CH), 
127.9 (CH), 128.6 (CH), 128.8 (CH), 130.6 (CH), 137.4 (C, 11-C), 140.28 (CH), 141.9 (C, 16-C), 
147.9 (C, 10-C), 167.5 (C, 9-C) CI MS m/z (%) 293 ([M+H]+, 100), 275 (15), 186 (7), 173 (5), 123 
(4), 107 (5); HRMS (CI) 293.1288 (C18H17N2O2 requires 293.1290).  
 
(R)-N-(2’-Hydroxy-2’-phenylethyl)-2-pyridyl-carbothioamide (R)-(43). Prepared by 
modification of the protocol developed by Masson.34 Amino alcohol 31b (1.20 g, 8.5 mmol) and 
triethylamine (1.12 mL, 8.5 mmol) were added to a solution of thioester 42 (1.05 g, 6.4 mmol) 
in THF and the reaction mixture was allowed to stir at room temperature for 18 h, after which 
the solvent was removed in vacuo. The residue was passed through a column of silica gel (35 g) 
with a petroleum ether-AcOEt mixture (1:1) to afford 43 as a colourless oil (1.289 g, 78%): 1H 
NMR (400 MHz, CDCl3) δH 3.82 (ddd, J = 10.1 Hz, J = 8.8 Hz, J = 4.8 Hz, 1H) 4.35 (ddd, J = 13.9 Hz, 
J = 7.1 Hz, J = 3.3 Hz, 1H) 5.11 (dd, J = 8.8 Hz, J = 3.3 Hz, 1H), 7.24 – 7.42 (m, 6H), 7.77 (dt, J = 7.8 
Hz, J = 1.7 Hz, 1H), 8.42 (ddd, J = 4.8 Hz, J = 1.8 Hz, J = 1.0 Hz, 1H), 8.63 (dt, 8.1 Hz, J = 1.0 Hz, 
1H), 10.50 (bs, 1H). The compound was used in the next step without further purification. 
 
(R)-(–)-N-(2’-tert-Butyldimethylsilanoxy-2’-phenylethyl)-1-isoquinolinyl-carboxamide 
(R)-(–)-(44). A solution of alcohol (R)-40 (500 mg, 1.71 mmol), tert-butyldimethylsilyl chloride 
(309 mg, 2.05 mmol), and imidazole (291 mg, 4.28 mmol) in DMF (5 mL) was stirred at room 
temperature overnight. The mixture was then diluted with aqueous NH4Cl and extracted with 
CH2Cl2. The organic phase was washed with brine (3 x 25 mL), dried over MgSO4, and the 
solvent was removed under reduced pressure to afford (R)-(−)-44 as a colourless oil (63%); [α]D 
-23.7 (c  1.00, CHCl3);  1H NMR (400 MHz, CDCl3) δH 0.01 (s, 6H), 0.82 (s, 9H), 3.36 (ddd, J = 13.89 
Hz, J = 8.4 Hz, J = 4.8 Hz, 1H), 3.90 (ddd, J = 13.6 Hz, J = 8.0 Hz, J = 4.0 Hz, 1H), 4.90 (dd, J = 8.4 
Hz, J = 4.0 Hz, 1H), 7.31 – 7.41 (m, 5H), 7.65 – 7.84 (m, 3H), 8.44 (d, J = 5.6 Hz, 1H), 8.62 (bs, 1H), 
9.61 (d, J = 5.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δC -4.6  (CH3, C-19), -3.6 (CH3, C-20), 18.2 (C-
21), 25.7 (CH3, C-22), 47.9 (CH2, C-1), 74.0 (CH, C-2); MS EI m/z (%) 406.14 (M+, 5), 349.11 (42), 
221.1 (100), 185.1 (35), 128.0 (54), 73.0 (60); HRMS 406.2077 (C24H30O2N2Si requires 406.2076); 
Anal. Calcd. for C24H30N2O2Si: C 70.90 H 7.44 N 6.89. Found C 70.81 H 7.44 N 6.69.  
 
(S)-(–)-N-(2’-Chloro-2’-phenylethyl)-2-pyridyl-carboxamide (S)-(–)-(45). Trichlorosilane 
(367 µL, 3.6 mmol, 8.1 equiv) was added to a solution of oxazoline (S)-17 (100 mg, 0.45 mmol, 
1.0 equiv) in CH2Cl2 (5 mL) at 0 ˚C and the mixture was stirred at room temperature overnight. 
The reaction was quenched with satd. NaHCO3 (aq) (10 mL) and the mixture was extracted with 
CH2Cl2 (3 × 20 mL) and the combined organic fractions were dried over MgSO4. Concentration 
under reduced pressure, followed by purification via column chromatography on silica gel 
(hexane-ethyl acetate, 1:1), gave (−)-45 (63 mg, 54%) as a white solid: mp 74-75 ˚C (ethyl 
acetate-hexane); [α]D –45.3 (c 0.4, CHCl3); IR (KBr) ν 1523, 1656 (amide C=O), 2938 (CH/CH2), 
3034 (Ar-H), 3336, 3373 (amide N−H) cm-1; 1H NMR (400 MHz, CDCl3) δH 3.74-3.81 (m, 1H), 
4.03-4.10 (m, 1H), 5.06 (dd, J = 9.2, 5.2 Hz, 1H), 7.25-7.41 (m, 6H), 7.78 (td, J = 8.0, 1.6 Hz, 1H), 
8.12 (d, J = 8.0 Hz, 1H), 8.38 (br s, 1H), 8.49 (d, J = 4.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δC 47.5 
(CH2), 62.5 (CH), 122.7 (CH), 126.8 (CH), 127.6 (2 × CH), 129.2 (2 × CH), 137.8 (CH), 138.5 (C), 
139.2 (C), 148.6 (CH), 149.9 (C), 164.9 (C); EI MS m/z (%) 262 (M+•{37Cl}, 3),  260 (M+•{35Cl}, 10), 
224 (10), 135 (100), 118 (15), 106 (90), 78 (98), 51 (18), 50 (4); HRMS (EI) 260.0714 and 
262.0689 (C14H1335ClN2O requires 260.0716, C14H1337ClN2O requires 262.0691). 
 
Di[1-(2’-methoxyphenyl)-ethyl]ether (47). Obtained from the reduction of 1f (Table 3, 
entry 9) as a 55:45 mixture of diastereoisomers by elution from silica gel as a less polar fraction 
than the main product using a petroleum ether-AcOEt mixture (20:1): colourless oil; 1H-NMR 
(400 MHz, CDCl3) δH 1.30 (m, d, J = 6.4 Hz, 6H, 2Me), 1.34 (M, d, J = 6.4 Hz, 6H, 2Me), 3.64 (m, s, 
6H, 2OMe), 3.67 (M, s, 6H, 2OMe), 4.10 (m, q, J = 6.4 Hz, 2H, 2CH), 4.16 (M, q, J = 6.4 Hz, 2H, 
2CH), 6.71 (M, d, J = 8.4 Hz, 2H), 6.76 (m, d, J = 8.0 Hz, 2H), 6.82 (M, t, J = 7.6, 2H), 6.96 (m, t, J = 
7.2, 2H), 7.10 (M, td, J = 8.0, 1.6 Hz, 2H), 7.17 (m, td, J = 8.0, 1.6 Hz, 2H), 7.39 (M, dd, J = 7.6, 1.6 
Hz, 2H), 7.50 (m, dd, J = 7.2, 1.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δC 22.8 (2 × CH3), 25.4 (CH), 
45.5 (CH2), 65.4 (CH), 79.7 (CH2), 123.9 (CH), 125.4 (CH), 136.6 (CH), 149.7 (CH), 162.5 (C), 165.1 
(C); IR (CHCl3) ν 1216 (C-O), 3019 (Aryl C-H) cm-1; EI MS m/z (%) 286 (M+•, 6), 271 (4), 178 (4), 
151 (6) 135 (100), 105 (13), 84 (9), 49 (11); HRMS (EI) 286.1569 (C18H22O3 requires 286.1568). 
 
Di(1-phenyl-1-buten-3-yl)ether (48).35 Obtained from the reduction of 1m (Table 3, 
entry 13) as a 1:1 mixturwe of diastereoisomers by elution from silica gel as a less polar fraction 
than the main product using a petroleum ether-AcOEt mixture (75:1): 1H-NMR (400 MHz, CDCl3) 
δH 1.26 and 1.28 (2 x d, J = 6.4 Hz, 2 x 6H, 2 x 2Me), 4.10 and 4.16 (2 x m, 2 x 2H, 2 x 2CH3CH), 
6.04 and 6.11 (2 x dd, 2 x J = 16.0, 7.6 Hz, 2 x 2H, 2 x 2CHCH=), 6.42 and 6.46 (2 x d, 2 x J = 16.0 
Hz, 2 x 2H, 2 x 2PhCH=), 7.12-7.36 (m, 2 x 10H, 2 x 2Ph) in agreement with literature data.35 
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